Financial Ratios China Rare Earth Holdings Limited OTC Markets
Stocks
CREQF
KYG210891001
Commodity Chemicals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.001100 USD | +10.00% |
|
-.--% | -99.49% |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.32 | 0.43 | -8.91 | -6 | -2.57 | |||||
Return on Total Capital | 0.33 | 0.45 | -9.41 | -6.33 | -2.71 | |||||
Return On Equity % | 0.77 | 0.9 | -15.24 | -9.7 | -5.44 | |||||
Return on Common Equity | 0.73 | 0.86 | -14.44 | -9.22 | -5.27 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 6.82 | 7.09 | 0.14 | -22.06 | -7 | |||||
SG&A Margin | 4.48 | 4.76 | 6 | 8.14 | 4.81 | |||||
EBITDA Margin % | 4.17 | 4.27 | -43.71 | -27.48 | -7.87 | |||||
EBITA Margin % | 1.29 | 1.68 | -48 | -31.93 | -11.29 | |||||
EBIT Margin % | 1.29 | 1.68 | -48 | -31.93 | -11.29 | |||||
Income From Continuing Operations Margin % | 1.85 | 2.1 | -48.58 | -30.55 | -14.16 | |||||
Net Income Margin % | 1.77 | 2 | -46.06 | -29.23 | -13.87 | |||||
Net Avail. For Common Margin % | 1.77 | 2 | -46.06 | -29.23 | -13.87 | |||||
Normalized Net Income Margin | 1.34 | 1.33 | -27.74 | -18.35 | -6.73 | |||||
Levered Free Cash Flow Margin | 9.42 | -0.23 | -2.58 | -7.71 | -34.96 | |||||
Unlevered Free Cash Flow Margin | 9.45 | -0.21 | -2.55 | -7.68 | -34.96 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.39 | 0.41 | 0.3 | 0.3 | 0.36 | |||||
Fixed Assets Turnover | 4.35 | 4.35 | 2.88 | 2.94 | 4.06 | |||||
Receivables Turnover (Average Receivables) | 3.09 | 2.43 | 1.59 | 1.53 | 1.51 | |||||
Inventory Turnover (Average Inventory) | 3.47 | 3.31 | 3.04 | 4.25 | 3.5 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 18.38 | 17.58 | 16.26 | 17.74 | 17.17 | |||||
Quick Ratio | 15.32 | 15.34 | 14.72 | 15.83 | 14.66 | |||||
Operating Cash Flow to Current Liabilities | 1.04 | 0.74 | -1.74 | -1.56 | -2.92 | |||||
Days Sales Outstanding (Average Receivables) | 118.42 | 150.19 | 228.94 | 238.15 | 242.89 | |||||
Days Outstanding Inventory (Average Inventory) | 105.34 | 110.41 | 120.09 | 85.97 | 104.54 | |||||
Average Days Payable Outstanding | 24.56 | 29.51 | 52.93 | 34.27 | 30.2 | |||||
Cash Conversion Cycle (Average Days) | 199.21 | 231.1 | 296.1 | 289.86 | 317.23 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 0.12 | 0.06 | 0.06 | 0.05 | 0.04 | |||||
Total Debt / Total Capital | 0.12 | 0.06 | 0.06 | 0.05 | 0.04 | |||||
LT Debt/Equity | 0.08 | 0.05 | 0.04 | 0.03 | 0.01 | |||||
Long-Term Debt / Total Capital | 0.08 | 0.05 | 0.04 | 0.03 | 0.01 | |||||
Total Liabilities / Total Assets | 5.04 | 5.14 | 5.53 | 5.09 | 5.35 | |||||
EBIT / Interest Expense | 32.73 | 44.71 | -1.31K | -708.89 | -2.03K | |||||
EBITDA / Interest Expense | 115.38 | 123.03 | -1.18K | -599.19 | -1.34K | |||||
(EBITDA - Capex) / Interest Expense | 103.79 | -75.22 | -1.2K | -599.25 | -1.34K | |||||
Total Debt / EBITDA | 0.07 | 0.03 | -0 | -0.01 | -0.01 | |||||
Net Debt / EBITDA | -34.21 | -32.48 | 4.14 | 7.01 | 17.15 | |||||
Total Debt / (EBITDA - Capex) | 0.07 | -0.05 | -0 | -0.01 | -0.01 | |||||
Net Debt / (EBITDA - Capex) | -38.03 | 53.12 | 4.06 | 7.01 | 17.15 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 9.21 | 9 | -33.16 | -15.34 | 10.29 | |||||
Gross Profit, 1 Yr. Growth % | -1.66 | 13.4 | -98.7 | -13.66K | -64.98 | |||||
EBITDA, 1 Yr. Growth % | -20.83 | 11.63 | -783.89 | -46.78 | -68.4 | |||||
EBITA, 1 Yr. Growth % | -45.44 | 41.25 | -2.01K | -43.69 | -60.99 | |||||
EBIT, 1 Yr. Growth % | -45.44 | 41.25 | -2.01K | -43.69 | -60.99 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -47.94 | 23.43 | -1.65K | -46.76 | -48.88 | |||||
Net Income, 1 Yr. Growth % | -49.31 | 23.16 | -1.64K | -46.28 | -47.68 | |||||
Normalized Net Income, 1 Yr. Growth % | -17.43 | 8.3 | -1.5K | -44.02 | -59.54 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -49.32 | 23.16 | -1.64K | -46.28 | -47.68 | |||||
Accounts Receivable, 1 Yr. Growth % | 74.81 | 17.93 | -11.72 | -12.18 | 39.91 | |||||
Inventory, 1 Yr. Growth % | 32.84 | 0.22 | -43.89 | 6.09 | 27.77 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -5.9 | 24.94 | -18.31 | -15.37 | -25.79 | |||||
Total Assets, 1 Yr. Growth % | 7.34 | 3.9 | -20.92 | -10.62 | -7.02 | |||||
Tangible Book Value, 1 Yr. Growth % | 7 | 3.76 | -20.6 | -9.77 | -7.12 | |||||
Common Equity, 1 Yr. Growth % | 7 | 3.76 | -20.6 | -9.77 | -7.12 | |||||
Cash From Operations, 1 Yr. Growth % | -197.08 | -24.4 | -300.33 | -26.34 | 84.22 | |||||
Capital Expenditures, 1 Yr. Growth % | -76.77 | 1.67K | -92.29 | -99.74 | - | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -159.98 | -102.67 | 646.64 | 153.1 | 400.39 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -160.27 | -102.39 | 723.74 | 154.44 | 402.18 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 11.04 | 9.11 | -14.64 | -24.78 | -3.37 | |||||
Gross Profit, 2 Yr. CAGR % | 12.02 | 5.6 | -87.87 | 32.66 | 589.07 | |||||
EBITDA, 2 Yr. CAGR % | -3.07 | -5.99 | 176.31 | 90.79 | -58.99 | |||||
EBITA, 2 Yr. CAGR % | 37.79 | -12.22 | 419.73 | 228.15 | -53.13 | |||||
EBIT, 2 Yr. CAGR % | 37.79 | -12.22 | 419.73 | 228.15 | -53.13 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 67.15 | -19.84 | 337.07 | 187.06 | -47.83 | |||||
Net Income, 2 Yr. CAGR % | 90.63 | -20.99 | 335.19 | 187.43 | -46.98 | |||||
Normalized Net Income, 2 Yr. CAGR % | 47.9 | -5.44 | 289.1 | 179.75 | -52.41 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 90.63 | -20.99 | 335.22 | 187.44 | -46.98 | |||||
Accounts Receivable, 2 Yr. CAGR % | 4.35 | 43.58 | 2.03 | -11.95 | 10.84 | |||||
Inventory, 2 Yr. CAGR % | 5.61 | 15.38 | -25.01 | -22.85 | 16.43 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 16.66 | 8.43 | 1.02 | -16.85 | -20.75 | |||||
Total Assets, 2 Yr. CAGR % | 2.89 | 5.61 | -9.35 | -15.93 | -8.84 | |||||
Tangible Book Value, 2 Yr. CAGR % | 3.09 | 5.36 | -9.24 | -15.36 | -8.45 | |||||
Common Equity, 2 Yr. CAGR % | 3.09 | 5.36 | -9.24 | -15.36 | -8.45 | |||||
Cash From Operations, 2 Yr. CAGR % | 61.59 | -14.33 | 23.07 | 21.47 | 16.49 | |||||
Capital Expenditures, 2 Yr. CAGR % | -48.89 | 102.71 | 16.81 | -98.59 | - | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 37.12 | -87.35 | -55.36 | 334.72 | 255.88 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 37.3 | -88 | -55.62 | 357.81 | 257.46 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 20.41 | 10.36 | -7.34 | -14.88 | -14.54 | |||||
Gross Profit, 3 Yr. CAGR % | 43.55 | 12.48 | -75.63 | 25.9 | -14.9 | |||||
EBITDA, 3 Yr. CAGR % | 53.52 | 1.6 | 82.16 | 59.57 | 4.77 | |||||
EBITA, 3 Yr. CAGR % | -31.26 | 38.94 | 145.17 | 147.77 | 61.35 | |||||
EBIT, 3 Yr. CAGR % | -31.26 | 38.94 | 145.17 | 147.77 | 61.35 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -37.59 | 51.08 | 115.04 | 116.66 | 61.5 | |||||
Net Income, 3 Yr. CAGR % | -38.03 | 64.79 | 112.53 | 116.69 | 62.9 | |||||
Normalized Net Income, 3 Yr. CAGR % | -8.52 | 33.31 | 132.09 | 103.89 | 46.85 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -38.04 | 64.79 | 112.53 | 116.7 | 62.9 | |||||
Accounts Receivable, 3 Yr. CAGR % | 48.97 | 8.69 | 22.09 | -2.94 | 2.75 | |||||
Inventory, 3 Yr. CAGR % | 25.37 | 3.78 | -9.27 | -15.82 | -8.72 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -0.93 | 19.36 | -1.34 | -4.77 | -19.94 | |||||
Total Assets, 3 Yr. CAGR % | 0.12 | 3.22 | -4.1 | -9.78 | -13.06 | |||||
Tangible Book Value, 3 Yr. CAGR % | 0.38 | 3.31 | -4.12 | -9.41 | -12.7 | |||||
Common Equity, 3 Yr. CAGR % | 0.38 | 3.31 | -4.12 | -9.41 | -12.7 | |||||
Cash From Operations, 3 Yr. CAGR % | 51.12 | 25.45 | 13.71 | 3.71 | 39.56 | |||||
Capital Expenditures, 3 Yr. CAGR % | -34.29 | 66.56 | -31.82 | -84.77 | - | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 19.86 | -63.12 | -50.74 | -20.4 | 355.59 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 20.74 | -64.41 | -50.85 | -20.56 | 372.15 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5.7 | 11.32 | 4.93 | -5.33 | -5.77 | |||||
Gross Profit, 5 Yr. CAGR % | -8.03 | 77.14 | -46.57 | 20.15 | -7.23 | |||||
EBITDA, 5 Yr. CAGR % | -18.63 | 17.41 | 94.2 | 30.73 | 0.33 | |||||
EBITA, 5 Yr. CAGR % | -41.4 | -24.59 | 54.4 | 95.94 | 26.48 | |||||
EBIT, 5 Yr. CAGR % | -41.4 | -24.59 | 54.4 | 95.94 | 26.48 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -40.12 | -25.1 | 35.95 | 95.31 | 22.04 | |||||
Net Income, 5 Yr. CAGR % | -40.15 | -25.28 | 35.13 | 105.86 | 21.96 | |||||
Normalized Net Income, 5 Yr. CAGR % | -33.38 | -20.6 | 63.23 | 79.32 | 23.14 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -41.21 | -25.28 | 35.13 | 105.87 | 21.96 | |||||
Accounts Receivable, 5 Yr. CAGR % | 6.22 | 19.23 | 28.04 | -0.09 | 17.46 | |||||
Inventory, 5 Yr. CAGR % | -0.05 | 12.07 | 2.07 | -7.82 | 0.25 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -9.17 | -0.6 | -0.15 | 3.29 | -9.62 | |||||
Total Assets, 5 Yr. CAGR % | -1.66 | 0.89 | -3.78 | -4.91 | -6.02 | |||||
Tangible Book Value, 5 Yr. CAGR % | -1.02 | 1.72 | -3.58 | -4.6 | -5.88 | |||||
Common Equity, 5 Yr. CAGR % | -1.02 | 1.72 | -3.58 | -4.6 | -5.88 | |||||
Cash From Operations, 5 Yr. CAGR % | -12.58 | -14.09 | 39.21 | 23.84 | 14.81 | |||||
Capital Expenditures, 5 Yr. CAGR % | -10.53 | 113.64 | -17.28 | -75.29 | - | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -13.29 | -62.3 | -19.26 | -1.06 | 8.65 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -13.17 | -63.15 | -19.09 | -1.13 | 8.69 |
Select your edition
All financial news and data tailored to specific country editions
















